Tirzepatide Research Peptide
Tirzepatide is a 39-amino-acid synthetic peptide that activates both the GIP and GLP-1 receptors, used in laboratory research on incretin pharmacology.
11 listed Tirzepatide presentations
Each presentation is a separate specification with its own product code. Open one to add it to your inquiry cart or to ask for a quote on WhatsApp. Pricing, availability and lot documents are confirmed for each order.
| Presentation | Per vial | Per box | Product code |
|---|---|---|---|
| Tirzepatide 5 mg → | 5 mg | 10 vials | TR5 |
| Tirzepatide 10 mg → | 10 mg | 10 vials | TR10 |
| Tirzepatide 15 mg → | 15 mg | 10 vials | TR15 |
| Tirzepatide 20 mg → | 20 mg | 10 vials | TR20 |
| Tirzepatide 30 mg → | 30 mg | 10 vials | TR30 |
| Tirzepatide 40 mg → | 40 mg | 10 vials | TR40 |
| Tirzepatide 50 mg → | 50 mg | 10 vials | TR50 |
| Tirzepatide 60 mg → | 60 mg | 10 vials | TR60 |
| Tirzepatide 80 mg → | 80 mg | 10 vials | TR80 |
| Tirzepatide 100 mg → | 100 mg | 10 vials | TR100 |
| Tirzepatide 120 mg → | 120 mg | 10 vials | TR120 |
Amounts are per vial. mg, IU and mL describe different quantities and are not interchangeable. For laboratory research use only.
About Tirzepatide
Tirzepatide is a 39-amino-acid synthetic peptide whose sequence is based on glucose-dependent insulinotropic polypeptide (GIP). It activates both the GIP receptor and the glucagon-like peptide-1 (GLP-1) receptor, which is why it is described as a dual incretin receptor agonist.
A C20 fatty diacid moiety, attached through a linker, binds albumin reversibly and gives the molecule a far longer half-life than the native incretin hormones. In incretin pharmacology it is the usual reference point for dual agonism, sitting between single-receptor GLP-1 analogues such as semaglutide and triple agonists such as retatrutide.
Research context
Laboratories use tirzepatide to study how combined GIP and GLP-1 receptor signaling differs from selective GLP-1 receptor activation: receptor-binding and cAMP assays, studies of biased agonism at the GLP-1 receptor, and preclinical models of glucose homeostasis and energy balance.
Because it is one of the most thoroughly characterized multi-receptor incretin peptides, it is also a standard comparator when newer dual and triple agonists are evaluated.
Tirzepatide is also the active ingredient of licensed pharmaceutical products in some markets. The material listed here is supplied for laboratory research only; it is not a pharmaceutical product and must not be used as one.
What to confirm for Tirzepatide
Check these points with our team before you order:
- The amount per vial you need. Each fill is a separate listing with its own product code, so a concentration-response design may call for more than one.
- The counter-ion and net peptide content stated on the lot documents, which determine how much peptide a vial actually contains.
- The number of boxes you need and the US delivery destination.
- Which lot documents you require before ordering, such as an identity or purity report.
Tirzepatide: frequently asked questions
How is tirzepatide different from semaglutide?
Semaglutide activates only the GLP-1 receptor, while tirzepatide activates both the GIP and GLP-1 receptors. Both are fatty-acid-modified peptides built for a long half-life, so they are often studied side by side to separate GLP-1-driven effects from combined GIP/GLP-1 effects.
Why are there so many tirzepatide strengths?
Each strength is the amount of peptide per vial, packed 10 vials per box. A wide range of fills lets a laboratory match the vial to its protocol instead of splitting larger vials. Every strength has its own specification page and product code.
Which Tirzepatide presentations are listed?
11 presentations are listed: 5 mg (TR5), 10 mg (TR10), 15 mg (TR15), 20 mg (TR20), 30 mg (TR30), 40 mg (TR40), 50 mg (TR50), 60 mg (TR60), 80 mg (TR80), 100 mg (TR100), 120 mg (TR120). Each is packed 10 vials per box, and every presentation has its own specification page and product code.
How do I request a quote for Tirzepatide?
Open the presentation you need and use Ask price to message PureForm Biosciences on WhatsApp, or add several materials to the inquiry cart and send them together. Pricing, current availability and lot documents are confirmed in that conversation.
Related research materials
- Semaglutide →Long-acting, fatty-acid-modified GLP-1 receptor agonist peptide.
- Retatrutide →Investigational triple agonist of the GIP, GLP-1 and glucagon receptors.
- Cagrilintide →Long-acting acylated analogue of the pancreatic hormone amylin.
- Mazdutide →Oxyntomodulin-based dual agonist of the GLP-1 and glucagon receptors.
- Survodutide →Investigational dual agonist of the glucagon and GLP-1 receptors.
- Liraglutide →Acylated GLP-1 receptor agonist with a C16 fatty-acid side chain.
Research Use Only. Tirzepatide is supplied strictly for laboratory research. It is not a drug, supplement or medical product and is not for human or veterinary consumption.